精制破伤风抗毒素

目前唯一有效的防治手段是及时注射精制破伤风抗毒素（TAT）或人破伤风免疫球蛋白（TIG），以中和血液中游离的毒素。

At present , the unique effective therapy is to inject tetanus anti-toxin ( TAT ) or human tetanus immunoglobulin ( TIG ) into patient to neutralize the exotoxin .

对抗破伤风毒素人源单克隆抗体G2、G6、G2+G6与精制破伤风抗毒素进行了中和效力比较试验。

The toxin neutralizing activity was detected by human MAbs G2 、 G6 、 G2 + G6 and horse anti tetanus antitoxin .

建立了旋转振荡法配制弗氏不完全佐荆（IFA）抗原，并在精制破伤风抗毒素（TAT）生产中，与传统方法配制的IFA抗原进行比较。

Established a rotating-shaking method for incomplete Freund 's . adjuvant ( IFA ) antigen 's preparation and compared this with IFA antigen which prepared by classic method when we produced highly finished tetanus antitoxin ( TAT ) .

表明这些人源单抗在中和毒力方面能够取代精制破伤风抗毒素，可满足临床试验需求。

These human monoclonal antibodies were novel replacement for clinical trial .